\
&
Contact us
\
&
Contact us
Published on | 2 months ago
ProgrammesDue to an administrative error you may have encountered problems/discrepancies during the submission process. The errors are corrected and you are encouraged to check your submission and to make sure you comply with the corrected requirements.
The errors concern:
1. The page limit of your proposal: According to the EIC Pathfinder Challenges Work Programme the page limit is 30 pages.
2. Part B Ethics section and Part B Security section: These are mandatory, while in the incorrect configuration they were marked as not mandatory. Please make sure you fill in and submit these to avoid having an incomplete proposal.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
